US Stock MarketDetailed Quotes

INO Inovio Pharmaceuticals

Watchlist
  • 2.1500
  • +0.0200+0.94%
Close Feb 14 16:00 ET
  • 2.1400
  • -0.0100-0.47%
Post 20:01 ET
77.61MMarket Cap-0.49P/E (TTM)

About Inovio Pharmaceuticals Company

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Company Profile

SymbolINO
Company NameInovio Pharmaceuticals
Listing DateDec 8, 1998
Founded1983
CEODr. Jacqueline E. Shea
MarketNASDAQ
Employees122
Fiscal Year Ends12-31
Address660 West Germantown Pike,Suite 110
CityPlymouth Meeting
ProvincePennsylvania
CountryUnited States of America
Zip Code19462-1111
Phone1-267-440-4200
Websitehttp://www.inovio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jacqueline E. Shea
  • President, Chief Executive Officer and Director
  • 2.07M
  • Peter D. Kies
  • Chief Financial Officer and Principal Accounting Officer
  • 988.73K
  • Michael John Sumner
  • Chief Medical Officer
  • --
  • Dr. Laurent Humeau, PhD
  • Chief Scientific Officer
  • 976.66K
  • Simon X. Benito
  • Chairman of the Board
  • 151.19K
  • Dr. David B. Weiner, PhD
  • Director
  • 201.79K
  • Wendy L. Yarno, M.B.A.
  • Independent Director
  • 123.69K
  • Jay P. Shepard
  • Independent Director
  • 119.31K
  • Dr. Roger D. Dansey, M.D.
  • Independent Director
  • 108.69K
  • Dr. Ann C. Miller, M.D.
  • Independent Director
  • 126.94K
  • Lota S. Zoth, C.P.A.
  • Independent Director
  • 118.69K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!